Pablo J Cagnoni sold $2.8M of Incyte (INCY)

Executed Sep 15, disclosed Sep 17, 2 days later.

Value, as filed

$2.8M

23,218 sh across 2 lots

Executed

Sep 15

the trade date, as filed

Disclosed

Sep 17

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Pablo J Cagnoni President, R&D profile →

Pablo J Cagnoni (President, R&D) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Incyte Corporation (INCY). The largest single filing was $2.8M of INCY (23,218 sh across 2 lots, as filed), executed Sep 15.

The name

INCY

Incyte Corporation INCY · Healthcare · 38 filings in 24 months ticker →

Healthcare · Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Pablo J Cagnoni in INCY

INCYSALE Incyte Corporation $1.4M
10,801 sh × $125.56
Exec Aug 19
Filed Aug 20 · 5:15 PM ET INCYSALE Incyte Corporation $1.3M
10,803 sh × $120.04
Exec Aug 12
Filed Aug 14 · 4:01 PM ET INCYSALE Incyte Corporation $1.3M
10,640 sh × $122.69
Exec Aug 5
Filed Aug 7 · 4:02 PM ET INCYSALE Incyte Corporation $1.9M
15,888 sh × $119.70
Exec Jul 31
Filed Aug 4 · 4:04 PM ET INCYSALE Incyte Corporation $1.8M
18,667 sh × $96.50
Exec Apr 17
Filed Apr 21 · 5:30 PM ET INCYSALE Incyte Corporation $1.8M
18,667 sh × $94.24
Exec Mar 17
Filed Mar 19 · 5:30 PM ET INCYSALE Incyte Corporation $1.9M
18,668 sh × $100.91
Exec Feb 19
Filed Feb 23 · 5:30 PM ET